FDAnews
www.fdanews.com/articles/196185-first-generic-of-daraprim-approved
Red_Approved_Stamp.gif

First Generic of Daraprim Approved

March 10, 2020

Cerovene gained FDA approval for its generic of Vyera’s Daraprim (pyrimethamine) for treatment of toxoplasmosis when used with a sulfonamide.

FDA Commissioner Stephen Hahn said the approval is especially important for patients such as pregnant women and HIV/AIDS patients who are more susceptible to toxoplasmosis infections.

The New York Attorney General previously filed suit against Vyera Pharmaceuticals for an alleged scheme to monopolize the treatment.

View today's stories